Alergia na orzeszki ziemne
Diagnostyka i diagnoza
Alergia na orzeszki ziemne stanowi istotne wyzwanie diagnostyczne ze względu na jej potencjalnie zagrażający życiu charakter oraz rosnącą częstość występowania. Diagnostyka powinna opierać się na kompleksowym wywiadzie klinicznym, badaniu fizykalnym oraz specjalistycznych testach, takich jak punktowe testy skórne (SPT) z reakcją ≥8 mm, oznaczenia swoistych IgE (sIgE) z progiem ≥15 kU/L oraz diagnostyka molekularna (CRD) identyfikująca przeciwciała przeciwko komponentom Ara h 1, Ara h 2, Ara h 3, Ara h 6, Ara h 8 i Ara h 9. Szczególnie wysoką wartość predykcyjną mają sIgE przeciwko Ara h 2 i Ara h 6, które korelują z ryzykiem anafilaksji. Nowoczesne metody, takie jak test aktywacji bazofilów (BAT) i test aktywacji komórek tucznych (MAT), wykazują wysoką swoistość (np. MAT 98%) i czułość (Hoxb8 MAT: 93% czułości, 96% swoistości przy stężeniu alergenu ≥100 ng/ml), przewyższając tradycyjne testy. Bead-based epitope assay (BBEA) osiąga dokładność diagnostyczną na poziomie 93%, redukując liczbę fałszywie dodatnich wyników.
- Alergia na orzeszki ziemne – Diagnostyka
- Wywiad kliniczny i badanie przedmiotowe
- Testy skórne
- Testy krwi
- Diagnostyka molekularna (CRD)
- Test aktywacji bazofilów i komórek tucznych
- Test prowokacji pokarmowej
- Nowe podejścia diagnostyczne
- Wyzwania diagnostyczne i interpretacja wyników
- Wnioski i najnowsze osiągnięcia
Alergia na orzeszki ziemne – Diagnostyka
Alergia na orzeszki ziemne to powszechny i potencjalnie zagrażający życiu stan, który dotyka zarówno dzieci, jak i dorosłych, z rosnącą częstością występowania na całym świecie. Jest to najczęstsza przyczyna anafilaksji związanej z pokarmem, dlatego precyzyjna diagnoza ma kluczowe znaczenie dla właściwego postępowania medycznego12. Diagnoza alergii na orzeszki ziemne powinna opierać się na kompleksowym podejściu, które obejmuje szczegółowy wywiad kliniczny, badanie przedmiotowe oraz specjalistyczne testy diagnostyczne.
Wywiad kliniczny i badanie przedmiotowe
Proces diagnostyczny rozpoczyna się od dokładnego wywiadu na temat objawów i historii medycznej pacjenta. Lekarz przeprowadza szczegółową rozmowę, koncentrując się na rodzaju i ilości spożytego pokarmu, początku i czasie trwania objawów oraz czynnikach łagodzących3. Istotne jest odnotowanie czasu wystąpienia objawów po ekspozycji na orzeszki ziemne oraz charakteru reakcji alergicznej. Następnie przeprowadzane jest badanie fizykalne, które pomaga w ocenie stanu pacjenta i wykluczeniu innych możliwych przyczyn objawów, takich jak nietolerancja pokarmowa4.
Warto podkreślić, że jeśli podejrzewa się alergię na orzeszki ziemne, pacjent powinien unikać kontaktu z orzeszkami do czasu konsultacji z zespołem medycznym. W przypadku ciężkiej reakcji należy natychmiast szukać pomocy medycznej5.
Testy skórne
Punktowe testy skórne (SPT) są preferowaną metodą testowania u pacjentów z historią zgodną z alergią pokarmową6. W teście tym na skórę przedramienia lub pleców nakłada się krople zawierające ekstrakt alergenu orzeszka ziemnego, a następnie nakłuwa się skórę igłą7. Jeśli pacjent jest uczulony na orzeszki ziemne, w ciągu 15 minut pojawi się bąbel (reakcja skórna) 8.
Brytyjskie Towarzystwo Alergii i Immunologii Klinicznej (BSACI) stwierdza, że bąbel o wielkości 8 mm jest wysoce predykcyjny dla alergii na orzeszki ziemne9. Im większa średnica bąbla w teście punktowym, tym większe prawdopodobieństwo, że występuje klinicznie istotna alergia na orzeszki ziemne10.
Testy krwi
Badania krwi mierzą odpowiedź układu odpornościowego na określone pokarmy. Sprawdzają one ilość przeciwciał typu alergicznego we krwi, znanych również jako immunoglobulina E (IgE)11. Podstawowe badanie to oznaczenie swoistych przeciwciał IgE (sIgE) przeciwko ekstraktowi orzeszka ziemnego. Poziom sIgE równy lub wyższy niż 15 kU/L jest wysoce predykcyjny dla alergii na orzeszki ziemne12.
Te testy mogą jedynie wskazywać na uczulenie (obecność przeciwciał) i nie przewidują nasilenia reakcji klinicznej13. Ważne jest, aby zrozumieć, że dodatni wynik testu na alergię pokarmową sam w sobie nie oznacza, że pacjent ma alergię pokarmową. Testy te są najlepiej wykorzystywane do potwierdzenia możliwej historii alergii pokarmowej IgE-zależnej i nie powinny być używane jako testy przesiewowe14.
Diagnostyka molekularna (CRD)
Diagnostyka oparta na komponentach (CRD) to nowoczesne podejście do diagnozy alergii, które koncentruje się na identyfikacji konkretnych białek alergennych w celu zapewnienia precyzyjnej diagnozy i spersonalizowanych planów leczenia15. CRD umożliwia analizę swoistych przeciwciał IgE przeciwko ściśle określonym cząsteczkom (komponentom), które tworzą alergen16.
Główne zastosowania CRD w alergii na orzeszki ziemne obejmują identyfikację poziomów sIgE danej osoby na określone cząsteczki orzeszków ziemnych, takie jak Ara h 1, Ara h 2, Ara h 3, Ara h 6, Ara h 8 i Ara h 91718. Identyfikacja konkretnych komponentów może przyczynić się do oceny potencjalnego ryzyka anafilaksji u pacjenta w odpowiedzi na spożycie orzeszków ziemnych, ponieważ niektóre komponenty mogą być związane z większym prawdopodobieństwem wystąpienia ciężkich reakcji alergicznych19.
Zgodnie z wynikami badań, obecność przeciwciał przeciwko komponentom Ara h 2 i Ara h 6 jest najsilniejszym predyktorem prawdziwej alergii na orzeszki ziemne20. sIgE do Ara h 2 wykazuje najlepszą dokładność diagnostyczną (optymalny współczynnik prawdopodobieństwa pozytywnego/negatywnego) i dzięki bardzo wysokiej swoistości jest najlepszym pojedynczym testem do diagnozy alergii na orzeszki ziemne, ponieważ znacznie zmniejsza fałszywie dodatnie diagnozy21.
CRD można traktować jako równoważny z IgE i SPT w potwierdzaniu alergii na orzeszki ziemne u pacjentów z wysokim ryzykiem klinicznym22. Dodatkowo CRD powinno być wykonywane u pacjentów z niepewną historią alergii na orzeszki ziemne i pozytywnym wynikiem SPT/sIgE na całe orzeszki ziemne23.
Test aktywacji bazofilów i komórek tucznych
Test aktywacji bazofilów (BAT) i test aktywacji komórek tucznych (MAT) to nowsze metody diagnostyczne. BAT mierzy aktywację bazofilów po stymulacji alergenem, a jego główną zaletą jest niska inwazyjność w porównaniu z testami prowokacyjnymi24.
MAT ocenia stopień, w jakim surowica pacjenta może wywoływać zmiany związane z alergią w hodowanych komórkach tucznych25. W badaniach MAT wykazał 98% swoistość w wykrywaniu alergii na orzeszki ziemne, co czyni go cennym narzędziem w diagnostyce alergii26.
Nowy typ BAT, pośredni BAT, wykorzystuje bazofilie dawcy i tylko małą ilość surowicy pacjenta (którą można przechowywać przez długi czas). Połączona reaktywność bazofilów dla Ara h2 i Ara h6 wykazała najwyższą dokładność (94%) dla rozpoznania alergii na orzeszki ziemne, z dodatnią i ujemną wartością predykcyjną odpowiednio 96% i 89%27.
Test prowokacji pokarmowej
Złotym standardem w diagnostyce alergii na orzeszki ziemne pozostaje doustny test prowokacji pokarmowej (OFC), najlepiej podwójnie zaślepiony, kontrolowany placebo test prowokacji pokarmowej (DBPCFC)2829. W tym teście pacjent spożywa rosnące ilości białka orzeszka ziemnego lub masła orzechowego pod nadzorem lekarza, aby sprawdzić, czy wystąpi reakcja30.
Początkowa dawka 3 mg białka pokarmowego (czyli 12,5 mg masła orzechowego o zawartości białka 24%) wydaje się odpowiednia, a maksymalna dawka to zwykle 3 g białka pokarmowego31. Testy te są wykonywane w kontrolowanym środowisku medycznym, aby zapewnić bezpieczeństwo i natychmiastową interwencję w przypadku wystąpienia reakcji32.
Chociaż DBPCFC jest złotym standardem, testy te są rzadko wykonywane w praktyce klinicznej ze względu na czasochłonność, pracochłonność procedur oraz postrzegane ryzyko ciężkich reakcji alergicznych33.
Nowe podejścia diagnostyczne
Test epitopowy
Bead-based epitope assay (BBEA) to nowe, zaawansowane narzędzie służące do diagnozowania alergii na orzeszki ziemne34. Test ten wykorzystuje mapowanie epitopów, czyli identyfikację specyficznych fragmentów białek alergennych, które rozpoznawane są przez układ odpornościowy. W badaniach wykazano, że test epitopowy dokładnie przewidywał alergię na orzeszki ziemne w 93% przypadków, co stanowi znaczącą poprawę w porównaniu z istniejącymi testami do diagnozowania alergii na orzeszki ziemne, w tym testami punktowymi skóry i testami krwi na swoiste IgE35.
Badacze stwierdzili, że dodatnie wyniki testów są poprawne w 92% przypadków, podczas gdy ujemne wyniki potwierdzono w 94% przypadków36. Test ten znacznie zmniejszy liczbę fałszywie dodatnich wyników, co będzie bardzo pomocne w postawieniu bardziej świadomej diagnozy alergii na orzeszki ziemne37.
Hoxb8 MAT
Nowy test Hoxb8 MAT (test aktywacji komórek tucznych) wykazał wyjątkową dokładność diagnostyczną. Przy wartości odcięcia 5,2% komórek CD107a-dodatnich, test osiągnął czułość 93% i swoistość 96% przy stężeniach alergenu 100 ng/ml lub wyższych. Wyniki te przewyższyły dokładność diagnostyczną zarówno testów SPT, jak i sIgE38.
Hoxb8 MAT stanowi znaczący postęp w diagnostyce alergii. W przeciwieństwie do tradycyjnych testów, uwzględnia on funkcjonalne właściwości przeciwciał IgE i integruje kluczowe parametry wpływające na reakcje alergiczne39.
Wyzwania diagnostyczne i interpretacja wyników
Diagnozowanie alergii na orzeszki ziemne może być skomplikowane. Objawy mogą się różnić w zależności od osoby, a pojedyncza osoba może nie zawsze doświadczać tych samych objawów podczas każdej reakcji4041. Dlatego ważne jest, aby diagnoza była postawiona w kontekście wszystkich narzędzi diagnostycznych i indywidualnej sytuacji pacjenta42.
Wśród wyzwań w stosowaniu testów klinicznych na alergię na orzeszki ziemne i inne pokarmy jest rozróżnienie między uczuleniem na alergen a prawdziwą alergią43. Prawdziwa alergia to pozytywny wynik testu alergicznego z towarzyszącymi objawami klinicznymi44.
Było wiele debat i krytyki dotyczącej nadrozpoznawalności alergii pokarmowej u dzieci w oparciu tylko o pozytywny wynik testu punktowego skóry lub immunologicznego45. Z perspektywy klinicznej ważne jest, aby zapewnić jasność co do diagnozy alergii na orzeszki ziemne, aby zoptymalizować wyniki zdrowotne i ograniczyć niepokój zdrowotny46.
Ograniczenia testów diagnostycznych
Wyniki testów na swoiste przeciwciała IgE przeciwko orzeszkom ziemnym muszą być interpretowane w kontekście oceny klinicznej pacjenta i historii ekspozycji na alergeny47. Ujemne wyniki dla IgE na całe orzeszki ziemne i dowolne komponenty orzeszków ziemnych nie wykluczają całkowicie możliwości klinicznie istotnych reakcji alergicznych po ekspozycji na orzeszki ziemne48.
Dodatnie wyniki dla IgE na całe orzeszki ziemne lub dowolne potencjalne komponenty alergizujące orzeszków ziemnych nie są diagnostyczne dla alergii na orzeszki ziemne i wskazują jedynie, że pacjent może być uczulony na orzeszki ziemne lub alergen reagujący krzyżowo49.
Tradycyjne testy diagnostyczne, takie jak testy skórne i oznaczenia IgE w surowicy, mają niską swoistość, co przyczynia się do nadrozpoznawalności alergii nawet u 60% pacjentów50. Testy diagnostyczne, takie jak punktowe testy skórne (SPT), swoiste IgE orzeszków ziemnych lub testy komponentowe, mają niską dodatnią wartość predykcyjną dla postawienia diagnozy alergii pokarmowej, ale wysoką ujemną wartość predykcyjną51.
Znaczenie multidyscyplinarnego podejścia
Ze względu na złożoność diagnostyki alergii na orzeszki ziemne, leczenie tego stanu zwykle wymaga zespołu multidyscyplinarnego. Większość pacjentów jest najpierw widziana przez lekarza podstawowej opieki zdrowotnej52, ale rozpoznanie alergii na orzeszki ziemne powinno być zawsze dokonywane przez alergologa z przeszkoleniem w zakresie postępowania w przypadku poważnych reakcji alergicznych53.
Ważne jest, aby pacjent nie przerywał diety eliminacyjnej bez konsultacji z lekarzem. Jeśli pacjent unikał orzeszków ziemnych z powodu podejrzenia alergii, nie powinien ich ponownie wprowadzać do diety bez porady medycznej54.
Wnioski i najnowsze osiągnięcia
Diagnostyka alergii na orzeszki ziemne ewoluuje dzięki zaawansowanym technologiom, takim jak diagnostyka molekularna, technologia mikromacierzy, testy aktywacji bazofilów, testy genetyczne oraz uczenie maszynowe, które obiecują większą dokładność i spersonalizowaną opiekę w porównaniu z tradycyjnymi metodami, takimi jak punktowe testy skórne, badania IgE w surowicy i doustne testy prowokacji pokarmowej55.
Integracja zaawansowanych technologii z ustalonymi podejściami ma potencjał zrewolucjonizowania diagnostyki i postępowania w alergii na orzeszki ziemne, ostatecznie poprawiając opiekę nad pacjentem i wyniki leczenia56.
Nowe badania nad testami diagnostycznymi, takimi jak BBEA czy Hoxb8 MAT, pokazują obiecujące wyniki w zakresie dokładności diagnostycznej i mogą prowadzić do zmniejszenia liczby fałszywych diagnoz oraz potrzeby przeprowadzania ryzykownych doustnych testów prowokacji pokarmowej5758.
W praktyce klinicznej najważniejsze elementy diagnostyczne w określaniu diagnozy alergii na orzeszki ziemne to wywiad kliniczny i wykrywanie uczuleń, także za pomocą diagnostyki opartej na komponentach. Jednak w przypadku niejasnych wyników zawsze należy stosować złoty standard – doustny test prowokacji pokarmowej59.
Kolejne rozdziały
Zapraszamy do dalszego czytania naszego leksykonu.
Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.
Materiały źródłowe
- #1 Peanut Allergy: Symptoms, Reaction, Tests & Treatmenthttps://my.clevelandclinic.org/health/diseases/21511-peanut-allergy
Peanut allergies happen when your immune system tries to protect you from a protein in peanuts that it mistakenly thinks is harmful. […] Peanut allergies are the most common food-related cause of anaphylaxis, which can lead to swelling in your airways or a severe drop in blood pressure. […] Call 911 or go to the ER at the first sign of severe symptoms. […] Healthcare providers diagnose peanut allergies by talking to you about your symptoms and performing allergy testing. […] Testing for peanut allergies might include: Allergy skin test. A provider pricks your skin with tiny amounts of allergens (including peanut protein) to see if you develop a reaction. […] Allergy blood test. A provider tests your blood for IgE antibodies to allergens. High levels of antibodies to peanut protein can indicate an allergy to peanuts depending on your history.
- #2 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Peanut allergy is a widespread and potentially life-threatening condition that affects both children and adults, with a growing incidence worldwide. […] Component-resolved diagnostics is a modern approach to allergy diagnosis that focuses on identifying specific allergenic proteins to provide precise diagnoses and personalized treatment plans. […] Component-resolved diagnostics is particularly valuable in peanut allergy diagnosis, helping to determine allergen components associated with severe reactions. […] The criterion standard, also called the gold standard, for diagnosing food allergy (including peanut allergy) remains an oral food challenge (OFC), ideally a double-blind placebo control food challenge (DBPCFC). […] The main advantage of BAT is its low invasiveness compared to provocation tests.
- #3 Peanut Allergy – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK538526/
Most primary care clinicians will encounter patients with a food allergy. Peanut allergy is usually lifelong and potentially fatal. This activity addresses the evaluation and management of peanut allergies and highlights the role of the interprofessional team in the care of patients with this condition. […] Summarize the evaluation of a patient with a peanut allergy. […] Diagnosis of a peanut allergy relies on patient history and physical exam. The type/amount of food ingested, onset/duration of symptoms, and relieving factors are key in making an accurate diagnosis. […] Skin testing is the preferred testing method in those patients with a history compatible with food allergies. […] Ultimately a clinician-supervised oral food challenge is the best and most reliable method for diagnosing peanut allergy.
- #4 Peanut allergy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/peanut-allergy/diagnosis-treatment/drc-20376181
Talking with your healthcare team about your symptoms and medical history starts the process of diagnosis. A physical exam usually follows and these next steps may be needed: […] A blood test can measure your immune system’s response to certain foods. It checks the amount of allergy-type antibodies in your bloodstream, also known as immunoglobulin E (IgE) antibodies. […] All these sources may help confirm a peanut allergy. Or they may point to another cause such as food intolerance. […] If you think you have a peanut allergy, avoid contact with peanuts until you can meet with your care team. If you have a severe reaction, seek emergency help.
- #5 Peanut allergy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/peanut-allergy/diagnosis-treatment/drc-20376181
Talking with your healthcare team about your symptoms and medical history starts the process of diagnosis. A physical exam usually follows and these next steps may be needed: […] A blood test can measure your immune system’s response to certain foods. It checks the amount of allergy-type antibodies in your bloodstream, also known as immunoglobulin E (IgE) antibodies. […] All these sources may help confirm a peanut allergy. Or they may point to another cause such as food intolerance. […] If you think you have a peanut allergy, avoid contact with peanuts until you can meet with your care team. If you have a severe reaction, seek emergency help.
- #6 Peanut Allergy – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK538526/
Most primary care clinicians will encounter patients with a food allergy. Peanut allergy is usually lifelong and potentially fatal. This activity addresses the evaluation and management of peanut allergies and highlights the role of the interprofessional team in the care of patients with this condition. […] Summarize the evaluation of a patient with a peanut allergy. […] Diagnosis of a peanut allergy relies on patient history and physical exam. The type/amount of food ingested, onset/duration of symptoms, and relieving factors are key in making an accurate diagnosis. […] Skin testing is the preferred testing method in those patients with a history compatible with food allergies. […] Ultimately a clinician-supervised oral food challenge is the best and most reliable method for diagnosing peanut allergy.
- #7 Peanut Allergy: Symptoms, Reaction, and Treatmenthttps://www.webmd.com/allergies/peanut-allergy-explained
To diagnose a peanut allergy, your doctor will first ask about your symptoms and medical history. Then, they may suggest a physical exam along with: […] A skin test. This can be used to diagnose a peanut allergy and rule out other types of allergies. A tiny amount of peanut extract is placed on the skin of your arm or back. Then, a doctor or nurse pricks your skin with a needle. If you’re allergic, a reaction will show up as a raised bump or rash. […] A blood test. A blood test looks for IgE antibodies in your blood, which are a sign of an allergic reaction. […] An oral food challenge. You’ll eat very small amounts of peanuts while in your doctor’s office, with medication on hand to treat you in case of a reaction. The amount of peanuts you eat will increase over time so the doctor can watch your response.
- #8 Peanut allergyhttps://dermnetnz.org/topics/peanut-allergy
Peanut allergy is an adverse immune response to a peanut allergen. Peanut allergy is the most common cause of food-related anaphylaxis. Peanut allergy is principally a clinical diagnosis based on the rapid development of allergic symptoms and signs after eating a peanut. Skin prick testing and serum specific IgE tests are used to identify sensitisation and to confirm the diagnosis. Skin prick testing involves placing a drop of peanut allergen on the skin, then pricking the skin to see if a weal is produced within 15 minutes. The British Society of Allergy and Clinical Immunology (BSACI) states that a weal 8 mm in size is highly predictive of peanut allergy. Serum specific IgE testing, also known as radioallergosorbent testing (RAST), is performed to detect allergen-specific IgE in the blood. Specific IgE 15 kU/L is highly predictive of peanut allergy. These tests do not predict the severity of clinical allergy. […] Confirmed peanut allergy needs a comprehensive management plan, which should be shared with the patient’s wider family, school, and/or workplace.
- #9 Peanut allergyhttps://dermnetnz.org/topics/peanut-allergy
Peanut allergy is an adverse immune response to a peanut allergen. Peanut allergy is the most common cause of food-related anaphylaxis. Peanut allergy is principally a clinical diagnosis based on the rapid development of allergic symptoms and signs after eating a peanut. Skin prick testing and serum specific IgE tests are used to identify sensitisation and to confirm the diagnosis. Skin prick testing involves placing a drop of peanut allergen on the skin, then pricking the skin to see if a weal is produced within 15 minutes. The British Society of Allergy and Clinical Immunology (BSACI) states that a weal 8 mm in size is highly predictive of peanut allergy. Serum specific IgE testing, also known as radioallergosorbent testing (RAST), is performed to detect allergen-specific IgE in the blood. Specific IgE 15 kU/L is highly predictive of peanut allergy. These tests do not predict the severity of clinical allergy. […] Confirmed peanut allergy needs a comprehensive management plan, which should be shared with the patient’s wider family, school, and/or workplace.
- #10https://link.springer.com/article/10.1007/s40629-021-00190-6
The larger the wheal diameter in the skin prick test, the higher the probability that a clinically relevant peanut allergy is present. […] The gold standard of a diagnosis of primary peanut allergy is a standardized, double-blind, placebo-controlled oral food challenge (DBPCFC). Oral titrated peanut food challenges can also be performed openly. However, this option should only be considered if there is a very high probability of a negative result. […] The diagnosis of peanut allergy should always be made in the context of all diagnostic tools and in the individual context. Only with the help of the interaction of all diagnostic tools can it be determined whether the diagnosis of a primary (systemic) or possibly secondary (pollen-associated) peanut allergy or exclusion of peanut allergy can be made.
- #11 Peanut allergy – Diagnosis and treatment – Mayo Clinichttps://www.mayoclinic.org/diseases-conditions/peanut-allergy/diagnosis-treatment/drc-20376181
Talking with your healthcare team about your symptoms and medical history starts the process of diagnosis. A physical exam usually follows and these next steps may be needed: […] A blood test can measure your immune system’s response to certain foods. It checks the amount of allergy-type antibodies in your bloodstream, also known as immunoglobulin E (IgE) antibodies. […] All these sources may help confirm a peanut allergy. Or they may point to another cause such as food intolerance. […] If you think you have a peanut allergy, avoid contact with peanuts until you can meet with your care team. If you have a severe reaction, seek emergency help.
- #12 Peanut allergyhttps://dermnetnz.org/topics/peanut-allergy
Peanut allergy is an adverse immune response to a peanut allergen. Peanut allergy is the most common cause of food-related anaphylaxis. Peanut allergy is principally a clinical diagnosis based on the rapid development of allergic symptoms and signs after eating a peanut. Skin prick testing and serum specific IgE tests are used to identify sensitisation and to confirm the diagnosis. Skin prick testing involves placing a drop of peanut allergen on the skin, then pricking the skin to see if a weal is produced within 15 minutes. The British Society of Allergy and Clinical Immunology (BSACI) states that a weal 8 mm in size is highly predictive of peanut allergy. Serum specific IgE testing, also known as radioallergosorbent testing (RAST), is performed to detect allergen-specific IgE in the blood. Specific IgE 15 kU/L is highly predictive of peanut allergy. These tests do not predict the severity of clinical allergy. […] Confirmed peanut allergy needs a comprehensive management plan, which should be shared with the patient’s wider family, school, and/or workplace.
- #13 Peanut allergyhttps://dermnetnz.org/topics/peanut-allergy
Peanut allergy is an adverse immune response to a peanut allergen. Peanut allergy is the most common cause of food-related anaphylaxis. Peanut allergy is principally a clinical diagnosis based on the rapid development of allergic symptoms and signs after eating a peanut. Skin prick testing and serum specific IgE tests are used to identify sensitisation and to confirm the diagnosis. Skin prick testing involves placing a drop of peanut allergen on the skin, then pricking the skin to see if a weal is produced within 15 minutes. The British Society of Allergy and Clinical Immunology (BSACI) states that a weal 8 mm in size is highly predictive of peanut allergy. Serum specific IgE testing, also known as radioallergosorbent testing (RAST), is performed to detect allergen-specific IgE in the blood. Specific IgE 15 kU/L is highly predictive of peanut allergy. These tests do not predict the severity of clinical allergy. […] Confirmed peanut allergy needs a comprehensive management plan, which should be shared with the patient’s wider family, school, and/or workplace.
- #14 What Food Allergy Tests Meanhttps://kidswithfoodallergies.org/living-with-food-allergies/new-food-allergy-diagnosis/what-food-allergy-tests-mean/
When trying to determine whether a child has a food allergy, allergy tests can be helpful tools in making a diagnosis. […] Doctors usually dont recommend allergy testing for non-IgE-mediated reactions. Allergy testing is not helpful for diagnosing this type of food allergy. […] If the doctor thinks your child may have an IgE-mediated food allergy, they may order allergy testing to help confirm the diagnosis. […] The four most common types of allergy tests are: Skin prick test, Specific IgE (sIgE) blood test, Component test, Oral food challenge. […] An oral food challenge (OFC) is a test done in your doctors office where an allergist and their staff feed your child increasing amounts of their suspected food allergen. […] OFCs are considered the gold standard for food allergy testing. […] With SPT and sIgE blood test, a positive test result for food allergy does not mean your child has a food allergy by itself. These tests are best used to help confirm a possible history for an IgE-mediated food allergy and should not be used as screening tests, at home tests, or large panels.
- #15 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Peanut allergy is a widespread and potentially life-threatening condition that affects both children and adults, with a growing incidence worldwide. […] Component-resolved diagnostics is a modern approach to allergy diagnosis that focuses on identifying specific allergenic proteins to provide precise diagnoses and personalized treatment plans. […] Component-resolved diagnostics is particularly valuable in peanut allergy diagnosis, helping to determine allergen components associated with severe reactions. […] The criterion standard, also called the gold standard, for diagnosing food allergy (including peanut allergy) remains an oral food challenge (OFC), ideally a double-blind placebo control food challenge (DBPCFC). […] The main advantage of BAT is its low invasiveness compared to provocation tests.
- #16 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://www.mdpi.com/2072-6643/15/24/5132
Other tests, like the skin prick test (SPT), serum specific IgE (sIgE), basophil activation test (BAT), and serum specific IgE to allergen molecules (CRD), are performed in clinical practice. […] The main advantage of BAT is its low invasiveness compared to provocation tests. […] Component-resolved diagnostics (CRD) is a modern approach that enables the analysis of specific IgE antibodies against tightly defined molecules (components) that constitute the allergen. […] The primary applications of CRD in peanut allergy involve identifying sIgE levels of an individual to specific peanut molecules. […] The identification of specific components can contribute to assessing a patientâs potential risk of anaphylaxis in response to peanut consumption, as certain components may be associated with a higher likelihood of severe allergic reactions.
- #17 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Another diagnostic option is measuring specific IgE antibodies for the extraction of a particular allergen. […] The primary applications of CRD in peanut allergy involve identifying sIgE levels of an individual to specific peanut molecules. […] The identification of specific components can contribute to assessing a patients potential risk of anaphylaxis in response to peanut consumption, as certain components may be associated with a higher likelihood of severe allergic reactions. […] SIgE to Ara h 2 had the best diagnostic accuracy measures (optimal positive/negative likelihood ratio), and with its very high specificity, it is the best single test for peanut allergy diagnosis because it significantly reduces false positive diagnosis. […] CRD can be treated as an equivalent to IgE and SPT in confirming peanut allergy in patients at high clinical risk.
- #18 PEANT – Overview: Peanut, IgE with Reflex to Peanut Components, IgE, Serumhttps://www.mayocliniclabs.com/test-catalog/overview/64756
Evaluating patients with suspected peanut allergy […] The diagnosis of peanut allergy is dependent upon the presence of compatible clinical symptoms in the context of peanut exposure, with support from identification of potential peanut-specific IgE allergen antibodies, either by skin testing or in vitro serology testing. […] Once an elevated antibody response to total peanut IgE extract is established, assessment for the presence of specific IgE antibodies to the most common peanut allergenic components will be performed. […] Testing begins with analysis of peanut IgE. If peanut IgE is negative (<0.10 kU/L), testing is complete. [...] If peanut IgE is 0.10 kU/L or greater, then 7 peanut components (Ara h 2, Ara h 1, Ara h 3, Ara h 6, Ara h 8, Ara h 9, and profilin Bet v2) are performed at an additional charge.
- #19 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Another diagnostic option is measuring specific IgE antibodies for the extraction of a particular allergen. […] The primary applications of CRD in peanut allergy involve identifying sIgE levels of an individual to specific peanut molecules. […] The identification of specific components can contribute to assessing a patients potential risk of anaphylaxis in response to peanut consumption, as certain components may be associated with a higher likelihood of severe allergic reactions. […] SIgE to Ara h 2 had the best diagnostic accuracy measures (optimal positive/negative likelihood ratio), and with its very high specificity, it is the best single test for peanut allergy diagnosis because it significantly reduces false positive diagnosis. […] CRD can be treated as an equivalent to IgE and SPT in confirming peanut allergy in patients at high clinical risk.
- #20 603916: Allergen Profile, Peanut, IgE With Component Reflexes | Labcorphttps://www.labcorp.com/tests/603916/allergen-profile-peanut-ige-with-component-reflexes
IgE to Ara h 2 has the best discriminative ability of all diagnostic tests for peanut allergy. It can accurately diagnose peanut allergy in 28% of patients but cannot be used to exclude a peanut allergy in an adult population. […] The presence of antibodies to Ara h 1 and/or Ara h 3 increases the risk of severe reactions. […] Reactivity to these dominant allergens at the time of diagnosis in a population of North American infants and toddlers with early-onset peanut allergy was found to be associated with future allergy persistence at age 13 years. […] Ara h 6 is a major peanut allergen showing similarity with Ara h 2 in many aspects. […] Up to 4 out of 100 peanut allergic patients are monosensitized to Ara h 6. […] IgE antibodies to the Ara h 8 are seldom associated with systemic reactions but more often to local reactions like oral allergy syndrome.
- #21 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Another diagnostic option is measuring specific IgE antibodies for the extraction of a particular allergen. […] The primary applications of CRD in peanut allergy involve identifying sIgE levels of an individual to specific peanut molecules. […] The identification of specific components can contribute to assessing a patients potential risk of anaphylaxis in response to peanut consumption, as certain components may be associated with a higher likelihood of severe allergic reactions. […] SIgE to Ara h 2 had the best diagnostic accuracy measures (optimal positive/negative likelihood ratio), and with its very high specificity, it is the best single test for peanut allergy diagnosis because it significantly reduces false positive diagnosis. […] CRD can be treated as an equivalent to IgE and SPT in confirming peanut allergy in patients at high clinical risk.
- #22 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Additionally, CRD should be performed in patients with an uncertain peanut allergy history and a positive SPT/sIgE to whole peanuts. […] The use of CRD, specifically the measurement of Ara h 6 and Ara h 2 among others, is applied in assessing the risk of a severe allergic reaction. […] CRD may be useful in predicting peanut immunotherapy effectiveness and durability of tolerance.
- #23 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Additionally, CRD should be performed in patients with an uncertain peanut allergy history and a positive SPT/sIgE to whole peanuts. […] The use of CRD, specifically the measurement of Ara h 6 and Ara h 2 among others, is applied in assessing the risk of a severe allergic reaction. […] CRD may be useful in predicting peanut immunotherapy effectiveness and durability of tolerance.
- #24 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Peanut allergy is a widespread and potentially life-threatening condition that affects both children and adults, with a growing incidence worldwide. […] Component-resolved diagnostics is a modern approach to allergy diagnosis that focuses on identifying specific allergenic proteins to provide precise diagnoses and personalized treatment plans. […] Component-resolved diagnostics is particularly valuable in peanut allergy diagnosis, helping to determine allergen components associated with severe reactions. […] The criterion standard, also called the gold standard, for diagnosing food allergy (including peanut allergy) remains an oral food challenge (OFC), ideally a double-blind placebo control food challenge (DBPCFC). […] The main advantage of BAT is its low invasiveness compared to provocation tests.
- #25 A New Diagnostic Test for Peanut Allergy – FoodAllergy.orghttps://www.foodallergy.org/fare-blog/new-diagnostic-test-peanut-allergy
A new method for diagnosing peanut allergy was outlined in a letter published last month in the Journal of Allergy and Clinical Immunology (JACI). This mast cell activation test was compared to other available diagnostic tests on the basis of sensitivity (the rate of true positive tests, in which a disease is successfully identified) and specificity (the rate of true negative tests, in which a disease that isnt present is successfully ruled out). […] Each test currently used to diagnose peanut allergy has some drawbacks: […] Developed by researchers at Kings College London, the new test described in the JACI letter is based on the activation of mast cells, which are similar to basophils and play a key role in allergic reactions. […] This mast cell activation test (MAT) assesses the extent to which peanut-treated serum from patients blood samples can trigger allergy-associated changes in commercially available cultured mast cells.
- #26 Peanut Allergy Diagnosis With New Blood Testhttps://www.healthline.com/health-news/new-blood-test-may-provide-safer-cheaper-way-to-detect-peanut-allergies
Researchers are developing a blood test for peanut allergies that could eliminate the need for the sometimes risky and expensive oral food challenge. […] A new blood test could make diagnosing peanut allergies a safer and cheaper process. […] The current method for diagnosing a peanut allergy uses a skin prick or IgE test to check for specific antibodies. But these exams can result in overdiagnosis and false positives. […] The new blood test, called the mast activation test (MAT), could act as a secondary tool if skin prick test results are inconclusive. […] The MAT is highly specific, meaning that when it’s positive it confirms peanut allergy with high certainty, reducing the number of patients needing challenges and particularly the number of patients reacting during challenges. […] The researchers said the MAT identified peanut allergies with a 98 percent specificity.
- #27 Reliable blood test (indirect BAT) for peanut allergy diagnosishttps://www.aaaai.org/tools-for-the-public/latest-research-summaries/the-journal-of-allergy-and-clinical-immunology-in/2022/blood
The gold standard for the diagnosis of a peanut allergy is an oral food challenge (OFC), but this is a time-consuming, patient-unfriendly and expensive test. A relatively cheap new blood test is the direct Basophil Activation Test (BAT), which mimics an allergic reaction in vitro. The direct BAT for peanut has shown to be a promising diagnostic tool for replacing the OFC. […] In The Journal of Allergy and Clinical Immunology: In Practice, Ruinemans-Koerts et al. evaluated and validated a new type of BAT, using donor basophils and only a small amount of patient serum (which can be stored for a long time); i.e. the indirect BAT. […] The combined basophil reactivity for Ara h2 and Ara h6 showed the highest accuracy (94%) for the diagnosis of a peanut allergy, with positive and negative predictive values of 96% and 89%, respectively.
- #28 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://pmc.ncbi.nlm.nih.gov/articles/PMC10746123/
Peanut allergy is a widespread and potentially life-threatening condition that affects both children and adults, with a growing incidence worldwide. […] Component-resolved diagnostics is a modern approach to allergy diagnosis that focuses on identifying specific allergenic proteins to provide precise diagnoses and personalized treatment plans. […] Component-resolved diagnostics is particularly valuable in peanut allergy diagnosis, helping to determine allergen components associated with severe reactions. […] The criterion standard, also called the gold standard, for diagnosing food allergy (including peanut allergy) remains an oral food challenge (OFC), ideally a double-blind placebo control food challenge (DBPCFC). […] The main advantage of BAT is its low invasiveness compared to provocation tests.
- #29https://link.springer.com/article/10.1007/s40629-021-00190-6
Accurate diagnosis of a primary, systemic peanut allergy is of crucial importance for affected individuals and their families. A confirmed diagnosis can protect those affected from future allergic and even severe life-threatening events and support them in their ability to cope with the disease. […] The diagnosis of IgE-mediated peanut allergy is based on several key diagnostic elements. Building on a thorough history (including dietary and symptom diary if necessary), a key element is the detection of peanut-specific sensitization. This can be done by skin prick tests or in vitro by determining the specific IgE against peanut extract or against individual proteins of peanut in the serum (component diagnostics). Finally, oral provocation testing is still considered the gold standard of diagnosis and clinical proof of peanut allergy.
- #30 Peanut Allergy: Symptoms, Reaction, Tests & Treatmenthttps://my.clevelandclinic.org/health/diseases/21511-peanut-allergy
Food challenge test. Under the supervision of your provider, you’ll eat small, increasing amounts of peanut protein or peanut butter to see if you have a reaction. […] The best way to manage peanut allergies is to avoid peanuts and food containing peanuts. […] If you’re accidentally exposed to peanuts and have an allergic reaction, your provider might give you or recommend you take or carry: An epinephrine auto-injector (EpiPen or Auvi-Q) to use at the first signs of a severe allergic reaction. […] If you think you or your child has a peanut allergy, talk to a healthcare provider (and avoid peanuts and peanut products until you do).
- #31 Peanut Allergy and Component-Resolved Diagnostics PossibilitiesâWhat Are the Benefits?https://www.mdpi.com/2072-6643/15/24/5132
Peanut allergy is a widespread and potentially life-threatening condition that affects both children and adults, with a growing incidence worldwide. […] Component-resolved diagnostics is a modern approach to allergy diagnosis that focuses on identifying specific allergenic proteins to provide precise diagnoses and personalized treatment plans. […] Component-resolved diagnostics is particularly valuable in peanut allergy diagnosis, helping to determine allergen components associated with severe reactions. […] The criterion standard, also called the âgold standardâ, for diagnosing food allergy (including peanut allergy) remains an oral food challenge (OFC), ideally a double-blind placebo control food challenge (DBPCFC). […] The initial dose of 3 mg of food protein (which is 12.5 mg of peanut butter with 24% protein content) seems adequate, and the maximum is usually 3 g of food protein.
- #32 How Does a Doctor Diagnose a Peanut Allergy? | Oak Brook Allergistshttps://www.oakbrookallergists.com/2021/07/09/how-does-a-doctor-diagnose-a-peanut-allergy/
Allergic reactions to peanuts can be severe and may manifest early in life. So, itâs crucial to have this diagnosed right away to prevent any life-threatening reactions. […] The best way to confirm this food allergy is to get diagnosed by a peanut allergy doctor. Being informed is the best way to save you from severe allergic responses in the future. […] Diagnosis starts with a discussion about your symptoms and medical history. […] A physical examination follows shortly after the discussion. After your assessment, your peanut allergy doctor may ask you to do the following: […] Your peanut allergy doctor may recommend an elimination diet if the cause of your symptoms is still uncertain. […] Your peanut allergy doctor may make you undergo a skin test. […] A blood test works by quantifying your immune systemâs response to peanuts. Your doctor will measure the number of immunoglobulin E (IgE) antibodies in your blood. High IgE numbers indicate an allergy.
- #33 Recent Advances in Diagnosis and Therapy for Peanut Allergy – Page 2https://www.medscape.com/viewarticle/809522_2
Several studies have suggested that component-resolved diagnostics could improve the specificity of peanut-allergy testing. […] Currently, such challenges are seldom performed in the clinic due to time and the labor-intensive nature of the procedures as well as the perceived risk for severe allergic reactions. […] However, it is important to point out that studies have not yet specifically correlated clinical severity with Ara h 2 IgE. […] Several functional assays such as the basophil activation tests and analysis of peanut-specific T-cell responses are currently being studied. However, currently there is a lack of evidence demonstrating that these tests have diagnostic value in peanut allergy. […] While not ready for prime time, combining component-resolved diagnostics, IgE epitope mapping and high-throughput microarray platforms may in the future allow for an assay that will result in better diagnostic capability and help identify patients at risk of persistent allergy.
- #34 Peanut Allergy Diagnosis: Current Practices, Emerging Technologies, and Future Directionshttps://www.mdpi.com/2313-5786/5/1/4
The bead-based epitope assay (BBEA) is a new cutting-edge tool commercially available as of 2023 in the United States that is increasingly used to diagnose peanut allergy. […] Emerging diagnostic approaches for peanut allergy can be divided into molecular allergy diagnostics, microarray technology, basophil activation tests, genetic testing, novel imaging techniques, and machine learning and AI, each with distinct advantages and limitations. […] Peanut allergy diagnosis is evolving with advanced technologies like molecular diagnostics, microarray technology, basophil activation tests, genetic testing, and machine learning, which promise greater accuracy and personalized care compared to traditional methods such as skin prick testing, serum IgE testing, and oral food challenges.
- #35 Epitope Mapping Test Diagnoses Peanut Allergy 93% of The Timehttps://www.allergicliving.com/2021/06/15/epitope-mapping-test-diagnoses-peanut-allergy-with-over-90-accuracy/
Epitope mapping blood test showed high rate of accuracy in peanut allergy. A blood test called âepitope mappingâ accurately predicted peanut allergy 93 percent of the time, a recent study finds. Researchers say the new test is a significant improvement on existing tests for diagnosing peanut allergy, including skin prick tests and allergen-specific IgE blood tests. Those current tests can be unreliable in determining who will actually experience an allergic reaction to peanuts. […] But if those were inconclusive or I needed further evidence, I would order this test, says the director emeritus of the Jaffe Food Allergy Institute at the Icahn School of Medicine at Mount Sinai. […] He says the new test is also one step closer to being able to eliminate the need for the oral food challenge to diagnose a peanut allergy.
- #36 Epitope Mapping Test Diagnoses Peanut Allergy 93% of The Timehttps://www.allergicliving.com/2021/06/15/epitope-mapping-test-diagnoses-peanut-allergy-with-over-90-accuracy/
The researchers found that positive tests are correct in 92 percent of cases, while negative tests were confirmed in 94 percent of cases. […] This test will significantly cut down those false positives in a way that will be very helpful to make a more informed diagnosis for peanut allergy, says Schroer, who wasnât involved in the research. […] The accuracy of this novel test brings us one step closer to eliminating the need to subject patients to an oral food challenge to diagnose peanut allergy. […] Sampson and his team have previously published research using epitope mapping and IgE to predict which toddlers will grow out of a peanut allergy. […] Theyâre also studying epitope mapping to diagnose allergies to other foods, including milk, tree nuts and shrimp.
- #37 Epitope Mapping Test Diagnoses Peanut Allergy 93% of The Timehttps://www.allergicliving.com/2021/06/15/epitope-mapping-test-diagnoses-peanut-allergy-with-over-90-accuracy/
The researchers found that positive tests are correct in 92 percent of cases, while negative tests were confirmed in 94 percent of cases. […] This test will significantly cut down those false positives in a way that will be very helpful to make a more informed diagnosis for peanut allergy, says Schroer, who wasnât involved in the research. […] The accuracy of this novel test brings us one step closer to eliminating the need to subject patients to an oral food challenge to diagnose peanut allergy. […] Sampson and his team have previously published research using epitope mapping and IgE to predict which toddlers will grow out of a peanut allergy. […] Theyâre also studying epitope mapping to diagnose allergies to other foods, including milk, tree nuts and shrimp.
- #38 Researchers make a major advancement in food allergy diagnosis – The Brighter Side of Newshttps://www.thebrighterside.news/post/researchers-make-a-major-advancement-in-food-allergy-diagnosis/
The findings revealed that the Hoxb8 MAT exhibited exceptional diagnostic accuracy. Using a cutoff of 5.2% CD107a-positive cells, the test achieved a sensitivity of 93% and specificity of 96% at allergen concentrations of 100 ng/mL or higher. These results surpassed the diagnostic accuracy of both SPT and sIgE tests. […] The Hoxb8 MAT represents a significant advancement in allergy diagnostics. Unlike traditional tests, it accounts for the functional properties of IgE antibodies and integrates key parameters influencing allergic reactions. […] The development of the Hoxb8 MAT underscores the importance of innovation in addressing global health challenges. Food allergies affect up to 10% of the population in some regions, primarily young children. By offering a safer, more accurate diagnostic method, the Hoxb8 MAT has the potential to reduce unnecessary dietary restrictions and improve patient outcomes.
- #39 Researchers make a major advancement in food allergy diagnosis – The Brighter Side of Newshttps://www.thebrighterside.news/post/researchers-make-a-major-advancement-in-food-allergy-diagnosis/
The findings revealed that the Hoxb8 MAT exhibited exceptional diagnostic accuracy. Using a cutoff of 5.2% CD107a-positive cells, the test achieved a sensitivity of 93% and specificity of 96% at allergen concentrations of 100 ng/mL or higher. These results surpassed the diagnostic accuracy of both SPT and sIgE tests. […] The Hoxb8 MAT represents a significant advancement in allergy diagnostics. Unlike traditional tests, it accounts for the functional properties of IgE antibodies and integrates key parameters influencing allergic reactions. […] The development of the Hoxb8 MAT underscores the importance of innovation in addressing global health challenges. Food allergies affect up to 10% of the population in some regions, primarily young children. By offering a safer, more accurate diagnostic method, the Hoxb8 MAT has the potential to reduce unnecessary dietary restrictions and improve patient outcomes.
- #40 Peanut Allergy | Causes, Symptoms & Treatment | ACAAI Public Websitehttps://acaai.org/allergies/allergic-conditions/food/peanut/
An allergy to peanuts is among the most common food allergies found in children in the United States. […] If you suspect a peanut allergy, see an allergist for diagnosis and treatment. […] Diagnosing a peanut allergy can be complicated. Symptoms can vary from person to person, and a single individual may not always experience the same symptoms during every reaction. […] Your allergist may recommend a skin test or blood test to help diagnose whether you have a peanut allergy or allergy to another substance. […] If your child is determined to be high risk, the guidelines recommend having them tested for peanut allergy. Your allergist may do this with a skin test or blood test.
- #41 Diagnosing Food Allergies | Symptoms &Treatment | ACAAI Public Websitehttps://acaai.org/allergies/testing-diagnosis/food-allergy-testing-and-diagnosis/
Food allergy testing is a very important step in diagnosing food allergies. […] If done correctly and interpreted by a board-certified allergist, skin tests or blood tests are reliable and can rule food allergy in or out. […] Your allergist will interpret the test results and use them to aid in a diagnosis. […] Diagnosing food allergies can be complicated. Symptoms of food allergy can vary from person to person, and a single individual may not always experience the same symptoms during every reaction. […] Your allergist will look at both your test results and your medical history to make a food allergy diagnosis. […] If you are diagnosed with food allergies, your allergist will prescribe an epinephrine auto-injector and teach you how to use it.
- #42https://link.springer.com/article/10.1007/s40629-021-00190-6
The larger the wheal diameter in the skin prick test, the higher the probability that a clinically relevant peanut allergy is present. […] The gold standard of a diagnosis of primary peanut allergy is a standardized, double-blind, placebo-controlled oral food challenge (DBPCFC). Oral titrated peanut food challenges can also be performed openly. However, this option should only be considered if there is a very high probability of a negative result. […] The diagnosis of peanut allergy should always be made in the context of all diagnostic tools and in the individual context. Only with the help of the interaction of all diagnostic tools can it be determined whether the diagnosis of a primary (systemic) or possibly secondary (pollen-associated) peanut allergy or exclusion of peanut allergy can be made.
- #43 Peanut Allergy Diagnosis: As Simple as Ara h 1, 2, and 3 | Consultant360https://www.consultant360.com/articles/peanut-allergy-diagnosis-simple-ara-h-1-2-and-3-0
Among the challenges in using clinical testing for peanut and other food allergies is differentiating sensitization to an allergen from a genuine allergy. […] Genuine allergy is a positive allergy test with associated clinical signs or symptoms. […] There has been much debate and criticism of the overdiagnosis of food allergy in children based on only the positive result of a skin prick test or immunoassay. […] Historically, the diagnosis of allergy to peanuts and other foods relied on skin testing. […] However, the NIAID panel guidelines do recommend skin prick testing to be done by clinicians who are trained to properly interpret the test results and to be prepared in the office to treat a potential adverse reaction from testing. […] The sensitivity of these laboratory assays ranges from 60% to 95%, and their specificity ranges from 30% to 95%.
- #44 Peanut Allergy Diagnosis: As Simple as Ara h 1, 2, and 3 | Consultant360https://www.consultant360.com/articles/peanut-allergy-diagnosis-simple-ara-h-1-2-and-3-0
Among the challenges in using clinical testing for peanut and other food allergies is differentiating sensitization to an allergen from a genuine allergy. […] Genuine allergy is a positive allergy test with associated clinical signs or symptoms. […] There has been much debate and criticism of the overdiagnosis of food allergy in children based on only the positive result of a skin prick test or immunoassay. […] Historically, the diagnosis of allergy to peanuts and other foods relied on skin testing. […] However, the NIAID panel guidelines do recommend skin prick testing to be done by clinicians who are trained to properly interpret the test results and to be prepared in the office to treat a potential adverse reaction from testing. […] The sensitivity of these laboratory assays ranges from 60% to 95%, and their specificity ranges from 30% to 95%.
- #45 Peanut Allergy Diagnosis: As Simple as Ara h 1, 2, and 3 | Consultant360https://www.consultant360.com/articles/peanut-allergy-diagnosis-simple-ara-h-1-2-and-3-0
Among the challenges in using clinical testing for peanut and other food allergies is differentiating sensitization to an allergen from a genuine allergy. […] Genuine allergy is a positive allergy test with associated clinical signs or symptoms. […] There has been much debate and criticism of the overdiagnosis of food allergy in children based on only the positive result of a skin prick test or immunoassay. […] Historically, the diagnosis of allergy to peanuts and other foods relied on skin testing. […] However, the NIAID panel guidelines do recommend skin prick testing to be done by clinicians who are trained to properly interpret the test results and to be prepared in the office to treat a potential adverse reaction from testing. […] The sensitivity of these laboratory assays ranges from 60% to 95%, and their specificity ranges from 30% to 95%.
- #46 Peanut Allergy Diagnosis: Current Practices, Emerging Technologies, and Future Directionshttps://www.mdpi.com/2313-5786/5/1/4
Peanut allergy presents a significant and growing public health concern, marked by its increasing prevalence and potential for severe allergic reactions. Traditional diagnostic methods, such as skin prick testing and serum IgE assays, serve as cornerstone approaches but often fall short in specificity, sensitivity, and risk stratification. […] This review explores the evolution of peanut allergy diagnostics, comparing traditional and emerging methodologies, and discusses their clinical implications, limitations, and future directions. The integration of advanced technologies with established approaches holds the potential to revolutionize peanut allergy diagnosis and management, ultimately enhancing patient care and outcomes. […] From a clinical standpoint, it is important to provide clarity regarding the diagnosis of peanut allergy to optimize health outcomes and limit health anxiety. In this paper, we will explore various diagnostic methods for peanut allergy, including both traditional approaches such as skin prick testing and serum IgE testing and emerging diagnostics like component-resolved diagnostics, oral food challenges, basophil and mast cell activation tests, bead-based epitope assays, genetic testing, microarray technology, novel imaging techniques, and the use of machine learning and artificial intelligence.
- #47 PEANT – Overview: Peanut, IgE with Reflex to Peanut Components, IgE, Serumhttps://www.mayocliniclabs.com/test-catalog/overview/64756
Results from peanut specific IgE antibody testing must be interpreted in the context of patient’s clinical evaluation and history of allergen exposures. […] Negative results for IgE to total peanut and any peanut components do not completely exclude the possibility of clinically relevant allergic responses upon exposure to peanut. […] Positive results for IgE to total peanut or any potential peanut allergenic components are not diagnostic for peanut allergy, and only indicate patient may be sensitized to peanut or a cross-reactive allergen.
- #48 PEANT – Overview: Peanut, IgE with Reflex to Peanut Components, IgE, Serumhttps://www.mayocliniclabs.com/test-catalog/overview/64756
Results from peanut specific IgE antibody testing must be interpreted in the context of patient’s clinical evaluation and history of allergen exposures. […] Negative results for IgE to total peanut and any peanut components do not completely exclude the possibility of clinically relevant allergic responses upon exposure to peanut. […] Positive results for IgE to total peanut or any potential peanut allergenic components are not diagnostic for peanut allergy, and only indicate patient may be sensitized to peanut or a cross-reactive allergen.
- #49 PEANT – Overview: Peanut, IgE with Reflex to Peanut Components, IgE, Serumhttps://www.mayocliniclabs.com/test-catalog/overview/64756
Results from peanut specific IgE antibody testing must be interpreted in the context of patient’s clinical evaluation and history of allergen exposures. […] Negative results for IgE to total peanut and any peanut components do not completely exclude the possibility of clinically relevant allergic responses upon exposure to peanut. […] Positive results for IgE to total peanut or any potential peanut allergenic components are not diagnostic for peanut allergy, and only indicate patient may be sensitized to peanut or a cross-reactive allergen.
- #50 peanut diagnostic — allergenis provider sitehttps://www.allergenis.com/peanut-diagnostic
pioneering food allergy diagnostics, in that we are applying threshold data to inform clinical management for the first time. highly informative and highly accurate diagnostics for peanut allergies. Current food allergy current diagnostics have low specificity, contributing to the over-diagnosis of as many as 60 percent of patients. Diagnostic tests such as skin prick testing (SPT), peanut sIgE, or component testing have a low positive predictive value for making a diagnosis of food allergy but high negative predictive value. With high concordance to OFC, the allergenis peanut diagnostic or bead-based epitope assay (BBEA) promises to significantly increase diagnostic accuracy to be greater than SPT, sIgE, and CRD for patients with food allergies. current diagnostics do not provide threshold data. Despite current diagnostics launching nearly 40 years ago, there has been little development to improve accuracy or to provide threshold data for clinical management. allergenis set out to provide an accurate method of threshold assignment. The Allergenis test, a bead-based epitope assay, will be the only validated test to provide threshold data (besides an OFC). The Allergenis Peanut Diagnostic (also known as BBEA) is different than current blood tests. It is a molecular diagnostic test that looks for the mechanistic cause of an inappropriate immune response to peanut. The test is more than just an improvement over past technologies; the epitope technology has allowed us to identify specific epitopes tied to an immune response. This allows us much higher specificity and sensitivity (lowering the over-diagnosis of peanut allergies). Testing was validated using only samples with double-blind, placebo controlled oral food challenge results (gold standard). Testing does not require fresh whole blood; testing is performed off a small amount of plasma and takes 5-7 business days for results.
- #51 peanut diagnostic — allergenis provider sitehttps://www.allergenis.com/peanut-diagnostic
pioneering food allergy diagnostics, in that we are applying threshold data to inform clinical management for the first time. highly informative and highly accurate diagnostics for peanut allergies. Current food allergy current diagnostics have low specificity, contributing to the over-diagnosis of as many as 60 percent of patients. Diagnostic tests such as skin prick testing (SPT), peanut sIgE, or component testing have a low positive predictive value for making a diagnosis of food allergy but high negative predictive value. With high concordance to OFC, the allergenis peanut diagnostic or bead-based epitope assay (BBEA) promises to significantly increase diagnostic accuracy to be greater than SPT, sIgE, and CRD for patients with food allergies. current diagnostics do not provide threshold data. Despite current diagnostics launching nearly 40 years ago, there has been little development to improve accuracy or to provide threshold data for clinical management. allergenis set out to provide an accurate method of threshold assignment. The Allergenis test, a bead-based epitope assay, will be the only validated test to provide threshold data (besides an OFC). The Allergenis Peanut Diagnostic (also known as BBEA) is different than current blood tests. It is a molecular diagnostic test that looks for the mechanistic cause of an inappropriate immune response to peanut. The test is more than just an improvement over past technologies; the epitope technology has allowed us to identify specific epitopes tied to an immune response. This allows us much higher specificity and sensitivity (lowering the over-diagnosis of peanut allergies). Testing was validated using only samples with double-blind, placebo controlled oral food challenge results (gold standard). Testing does not require fresh whole blood; testing is performed off a small amount of plasma and takes 5-7 business days for results.
- #52 Peanut Allergy – StatPearls – NCBI Bookshelfhttps://www.ncbi.nlm.nih.gov/books/NBK538526/
To date, the recommended management of peanut allergy relies on avoidance of peanut ingestion. […] Although avoidance is the mainstay of treatment, new strategies are being tested to prevent food allergies. Peanut immunotherapy clinical trials have been promising to date using incremental ingestion of small amounts of peanut over time with oral immunotherapy (OIT). […] Managing a peanut allergy usually involves an interprofessional team. The majority of patients are first seen by the primary care clinician.
- #53 Peanut, tree nut, and seed allergy: Diagnosis – UpToDatehttps://www.uptodate.com/contents/peanut-tree-nut-and-seed-allergy-diagnosis
Peanut, tree nut, and seed allergies are some of the most common food allergies in both children and adults. These allergies tend to cause severe reactions and usually persist over time. […] The diagnosis of peanut, tree nut, and seed allergies is presented in this topic review. […] An unequivocal history of an immediate reaction consisting of typical allergic symptoms following the isolated ingestion of a peanut, tree nut, or seed product, supported by positive tests for specific immunoglobulin E (IgE) antibodies, is usually sufficient to establish the diagnosis for suspected IgE-mediated reactions. […] Either skin prick tests or in vitro tests for IgE are usually performed initially. […] With the exception of in vitro immunoassays for specific IgE, other diagnostic allergy procedures, including skin testing and food challenges, should be performed by allergy specialists with training in the management of serious allergic reactions.
- #54 Peanut Allergy | Allergy UK | National Charityhttps://www.allergyuk.org/resources/peanut-allergy-factsheet/
Peanut allergy affects around 2% (1 in 50) of children in the UK and has been increasing in recent decades. […] It is important to seek advice from a Healthcare professional if a peanut allergy is suspected. In the first instance, this will usually be your GP. They may arrange for allergy testing to be carried out or refer you to a specialist allergy service for skin prick testing and/or specific IgE blood testing to peanut. These tests help to confirm if food allergy is likely and rule out other possible causes. […] Allergy tests cannot predict how mild or severe an allergic reaction will be, or when an allergic reaction is likely to happen. […] If you have had cause for concern over peanut allergy and have been avoiding peanuts, it is important not to reintroduce peanuts back into the diet without medical advice.
- #55 Peanut Allergy Diagnosis: Current Practices, Emerging Technologies, and Future Directionshttps://www.mdpi.com/2313-5786/5/1/4
The bead-based epitope assay (BBEA) is a new cutting-edge tool commercially available as of 2023 in the United States that is increasingly used to diagnose peanut allergy. […] Emerging diagnostic approaches for peanut allergy can be divided into molecular allergy diagnostics, microarray technology, basophil activation tests, genetic testing, novel imaging techniques, and machine learning and AI, each with distinct advantages and limitations. […] Peanut allergy diagnosis is evolving with advanced technologies like molecular diagnostics, microarray technology, basophil activation tests, genetic testing, and machine learning, which promise greater accuracy and personalized care compared to traditional methods such as skin prick testing, serum IgE testing, and oral food challenges.
- #56 Peanut Allergy Diagnosis: Current Practices, Emerging Technologies, and Future Directionshttps://www.mdpi.com/2313-5786/5/1/4
Peanut allergy presents a significant and growing public health concern, marked by its increasing prevalence and potential for severe allergic reactions. Traditional diagnostic methods, such as skin prick testing and serum IgE assays, serve as cornerstone approaches but often fall short in specificity, sensitivity, and risk stratification. […] This review explores the evolution of peanut allergy diagnostics, comparing traditional and emerging methodologies, and discusses their clinical implications, limitations, and future directions. The integration of advanced technologies with established approaches holds the potential to revolutionize peanut allergy diagnosis and management, ultimately enhancing patient care and outcomes. […] From a clinical standpoint, it is important to provide clarity regarding the diagnosis of peanut allergy to optimize health outcomes and limit health anxiety. In this paper, we will explore various diagnostic methods for peanut allergy, including both traditional approaches such as skin prick testing and serum IgE testing and emerging diagnostics like component-resolved diagnostics, oral food challenges, basophil and mast cell activation tests, bead-based epitope assays, genetic testing, microarray technology, novel imaging techniques, and the use of machine learning and artificial intelligence.
- #57 Allergenis Seeks to Change Peanut Allergy Testing | 360DxRSS FeedsVisit 360Dx on TwitterVisit 360Dx on LinkedInhttps://www.360dx.com/immunoassays/allergenis-seeks-change-peanut-allergy-testing
NEW YORK â Pennsylvania-based firm Allergenis plans to change the model for peanut allergy testing with its blood test, which it said can reduce false diagnoses of peanut allergies and give nuanced results that will help patients manage their individual risk. […] According to Allergenis, its laboratory-developed test produces fewer false positive results than other first-line assays â skin prick and peanut-specific immunoglobulin E tests â and fewer false negative results than skin prick tests in young patients. […] Allergenis said study results show its test is 93 percent accurate, a measurement achieved by testing patients with both the Allergenis assay and oral food challenge and comparing the results. […] The assay has 92 percent sensitivity, which is comparable to skin prick and IgE tests. Its big advantage is its 94 percent specificity.
- #58 Researchers make a major advancement in food allergy diagnosis – The Brighter Side of Newshttps://www.thebrighterside.news/post/researchers-make-a-major-advancement-in-food-allergy-diagnosis/
The findings revealed that the Hoxb8 MAT exhibited exceptional diagnostic accuracy. Using a cutoff of 5.2% CD107a-positive cells, the test achieved a sensitivity of 93% and specificity of 96% at allergen concentrations of 100 ng/mL or higher. These results surpassed the diagnostic accuracy of both SPT and sIgE tests. […] The Hoxb8 MAT represents a significant advancement in allergy diagnostics. Unlike traditional tests, it accounts for the functional properties of IgE antibodies and integrates key parameters influencing allergic reactions. […] The development of the Hoxb8 MAT underscores the importance of innovation in addressing global health challenges. Food allergies affect up to 10% of the population in some regions, primarily young children. By offering a safer, more accurate diagnostic method, the Hoxb8 MAT has the potential to reduce unnecessary dietary restrictions and improve patient outcomes.
- #59https://link.springer.com/article/10.1007/s40629-021-00190-6
Peanut allergy is an immunoglobulin E (IgE)-mediated immune response that usually manifests in childhood and can range from mild skin reactions to anaphylaxis. Since quality of life may be greatly reduced by the diagnosis of peanut allergy, an accurate diagnosis should always be made. […] Important diagnostic elements include a detailed clinical history, detection of peanut-specific sensitization by skin prick testing and/or in vitro measurement of peanut (extract)-specific IgE and/or molecular components, and double-blind, placebo-controlled food challenge as the gold standard. […] The most important diagnostic measures in determining the diagnosis of peanut allergy are clinical history and detection of sensitizations, also via component-based diagnostics. However, in case of unclear results, the gold standardâan oral food challengeâshould always be used.